Total Tau Antibodies

Tau is a microtubule‑associated protein essential for maintaining neuronal structure and axonal stability. Elevated concentrations of total Tau in CSF and plasma reflect neuroaxonal injury and are observed across a wide range of neurological and neurodegenerative conditions1,2. Total Tau is therefore considered a general marker of neuronal damage rather than a disease‑specific indicator and is used to support the assessment of neurodegeneration in clinical and research settings.

Our wide portfolio of antibodies, targeting epitopes across the tau protein, can be used for the development of immunoassays aimed at quantifying Tau and characterizing neuroaxonal injury.

Contact sales for information
ADx201 - mAb mouse anti total tau – Pro-rich domain

Product number 90597

1 mg
ADx202 - mAb mouse anti total tau – Pro-rich domain

Product number 90599

1 mg
ADx204 - mAb mouse anti Tau – N-term

Product number 90508

1 mg
ADx215 - mAb mouse anti total tau – N-term

Product number 90561

1 mg
ADx216 - mAb mouse anti Tau – C-term

Product number 90604

1 mg
ADx218 - mAb recombinant mouse anti Tau - N-term

Product number 90563

1 mg

Click here to navigate

  • Contact sales for information
  • Details
  • Insights
  • Product inquiry
  • Related products
  • Webinars

  • Details

    References:

    1. Kang et al. Alzheimer Disease Biomarkers: Moving from CSF to Plasma for Reliable Detection of Amyloid and tau Pathology. Clin Chem. 2023 Nov 2;69(11):1247-1259.
    2. De Vos et al. Neurogranin and tau in cerebrospinal fluid and plasma of patients with acute ischemic stroke. BMC Neurol. 2017 Aug 30;17(1):170.

  • Insights

  • Product inquiry

    CAPTCHA

    The provision of your data implies your consent to the processing of your data in our database and, depending on the option you choose, to receiving our monthly newsletter by e-mail.

    For more information on how we process your personal data and regarding the rights you have in this respect, we refer to our privacy policy, which we hold at your disposal HERE.

    If you no longer wish to receive our newsletter, you have the option to unsubscribe via the ‘unsubscribe’ tool at the bottom of the newsletter. If you want to have your data removed from our database, please contact us at: privacy@fujirebio.com.

    • Review past webinars

    Neurodegenerative diseases
    Replay available
    2026/03/03 - 10:00 AM EST / 16:00 CET

    Mapping Synaptic Loss: Where β‑synuclein Fits in the Biomarker Landscape

    Watch replay
    Neurodegenerative diseases
    Replay available
    2025/11/19 - 10:00 AM EST / 16:00 CET

    Unlocking the biology of dementia with Lewy bodies: Biomarker insights from DDC to synapses

    Watch replay
    Neurodegenerative diseases
    Replay available
    2021/11/18 - 18 November 2021

    Preparing for the future of plasma based Alzheimers disease diagnostics

    Watch replay

Veuillez confirmer que vous êtes un professionnel de la santé

Le contenu de ce site web est en partie réservé aux professionnels de santé qui sont directement impliqués dans la fourniture de services de soins de santé aux patients. Si vous êtes un professionnel de santé et que vous disposez de tous les droits d'accès, veuillez confirmer en cliquant sur le bouton 'oui'.

Choose your country or region

Once you have made this selection we will show you only the content that is relevant for your country. You can change this setting any time by clicking on the flag in the top toolbar of our website and choosing another country.
The content of this website is in part restricted to healthcare professionals who are directly involved in the provision of healthcare services to patients. If you are a health professional and you have full access rights, please check this box and confirm below.